Neurotransmitter
The pages of this web site article contain an in depth discussion of a new and highly effective
neurotransmitter approach to treating
medical patients in clinics without drugs or
drug side effects. While on the surface this
approach may appear similar to treatment attempted by others
in the past, it is
differentiated from other approaches by the high
degree of effectiveness achieved and the unique
way the individual components are used. This approach
was developed by medical doctors caring for medical patients in their clinics while data basing treatment results. If you need assistance in finding a care giver using the NeuroResearch Clinics no-drug approach in treatment, we can help.
The research of NeuroResearch Clinics is guided
by the largest privately
held neurotransmitter data base in
the world. The
neurotransmitter data base documents
approximately 1.5 million patient-days of
treatment from over 650 clinics.
The research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter
testing research of NeuroResearch Clinics. The
first University of Minnesota Medical School neurotransmitter testing paper has been accepted for publication in "The
Journal of NeuroPsychiatry". It will be published in March of 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter tests in treatment of
depression.
Working with nutrients and neurotransmitter tests are not
intuitive. Few things
anticipated in neurotransmitter
studies actually happened. Without the
neurotransmitter statistical data
base analysis optimal
treatment would have never been defined.
Its
no secret, NeuroResearch Clinics uses the
nutrients 5-HTP, tyrosine, levodopa, and cysteine
with neurotransmitter
tests as indicted to treat disease.
Proper use these simple ingredients
is not simple.
Occasionally a patient will say,
"Why should I take that, I buy it in
a health food store?" People off the street
buying neurotransmitter nutrients in a health food store is like going to an art
store and buying oil
paints then going home and expecting
to paint like a master artist with no previous
painting experience. This is sophisticated
neurotransmitter medical treatment. Nutrients have
tremendous neurotransmitter
treatment
potential due to the
chemical properties. This
neurotransmitter is only fully realized by the
trained professional.
The focus of neurotransmitter
research is:
-
Serotonin
-
Dopamine
-
Norepinephrine
-
Epinephrine
Function, regulation, and neurotransmitter control is
far reaching being involved directly or indirectly with
every function of the body. NeuroResearch Clinics is
focused on treatment of over 80 neurotransmitter
diseases.
Nothing is intuitive! It was thought when 5-HTP was
taken the urinary neurotransmitter
serotonin increased. NeuroResearch Clinics has been
teaching, "There is no correlation between 5-HTP dosing and urinary
serotonin levels" therefore baseline
neurotransmitter tests prior to
treatment has no value, yet there are labs promoting its
use. In 2008 the
University of Minnesota Medical School in 2008 settled
the neurotransmitter baseline testing controversy in writing on the neurotransmitter research
of NeuroResearch Clinics, "Curiously,
5-HTP did not exhibit a clear influence on urinary
serotonin excretion when 5-HTP doses were compared to
urinary serotonin excretion".
Many of the neurotransmitter findings and treatment
outcomes are discussed on this web site.
Neurotransmitter treatment with nutrients are not
straight forward and require training. Since the year
2000 NeuroResearch Clinics has trained hundreds of
doctors in two day American Medical Association
certified category 1 neurotransmitter continuing medical education courses.
The
NeuroResearch Clinics Peer Reviewed research
The research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter
testing research of NeuroResearch Clinics. The
first University of Minnesota Medical School neurotransmitter testing
paper has been accepted for publication in "The
Journal of NeuroPsychiatry". It will be published in March of 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
neurotransmitter
|